Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

OncoGenex Pharmaceuticals (OGXI)

Add to Watchlists
Create an Alert
10.47 +0.04  +0.38% NASDAQ Apr 24, 3:24PM BATS Real time Currency in USD
View Full Chart
OGXI Price Chart
View All Events

OGXI Events

Date Type Description
Mar 11 Misc OncoGenex Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
Mar 11 Earnings OncoGenex Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: -0.62.
Nov 07 Misc OncoGenex to Report Financial Results for Third Quarter Conference Call
Nov 07 Earnings OncoGenex to Report Financial Results for Third Quarter 2013 and Address Key Questions From Investors on November 7, 2013. Estimate: -0.69.
Aug 08 Misc OncoGenex to Webcast Discussion of Clinical Development Program and Second Quarter 2013 Financial Results on August 8, 2013
Aug 08 Earnings OncoGenex Announces Second Quarter 2013 Financial Results on August 8, 2013. Estimate: -0.63.
May 24 Misc AGM Event for OncoGenex Pharmaceuticals Inc
May 02 Misc OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013
May 02 Earnings OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013. Estimate: -0.68.
View All Performance Charts

OGXI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OncoGenex Pharmaceuticals is down 1.87% over the last year vs S&P 500 Total Return up 21.56%, Actelion up 67.22%, and Bioline Rx up 12.30%.

Get Quote for
Advertisement

Portfolio Strategies Featuring OGXI

Did OncoGenex Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OGXI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Washington
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development & commercialization of therapies that address treatment resistance in cancer patients. It has three product candidates in pipeline: custirsen, apatorsen & OGX-225.

Recent Quotes

Symbol Price Chg Chg % Market Cap
OGXI 10.47 +0.04 +0.38% 153.99M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.